The fat redistribution syndrome in patients infected with HIV: Measurements of body shape abnormalities

Journal of the American Dietetic Association

Volumn 101, Issue 10, 2001, Pages 1175-1180

  Gerrior, Jul ^a   Kantaros, Julie ^b   Coakley, Eoin ^b   Albrecht, Mary ^b   Wanke, Christine ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY CONSTITUTION; BODY HEIGHT; BODY IMAGE; BODY WEIGHT; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; LIPODYSTROPHY; MALE; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BODY COMPOSITION; BODY CONSTITUTION; BODY HEIGHT; BODY IMAGE; BODY WEIGHT; DISEASE PROGRESSION; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMAN; LIPODYSTROPHY; MALE; MIDDLE AGE;

EID: 0035491403     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(01)00287-5     Document Type: Article

References (26)

1. Carr A, Samaras K, Burton S, Law M, Freund J, Chisolm DJ, Cooper DA. A Syndrome of peripheral lipodystrophy, hyperlidemia and insulin resistance due to HIV protease inhibitors. AIDS. 1998;12:F51-58.
2. Wong-Beringer A, Beringer P, Lovett MA. Hypertrophy of breasts in a patient treated with indinavir. Clin Infect Dis. 1997;25:937.
3. Striker R, Conlin D, Marz M, Wiviott. Localized adipose tissue hypertrophy in patients receiving immunodeficiency virus protease inhibitors. Clin Infect Dis., 1998.27:218-220.
4. Lipsky, J. Abnormal fat accumulation in patients with HIV-1 infection. Lancet. 1998.351; 847-848.
5. Miller KK, Daly PA, Sentochnik D, Doweiko J, Samore M, Basgoz No, Grinspoon. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis. 1998:27;68-72.
6. Roth VR, Kravcik S, Angel JB. Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors. Clin Infect Dis. 1998; 27: 65-70.
7. th World AIDS Conference, 1998. Abstract # 12373.
8. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. Buffalo hump in HIV infected patients on antiretroviral therapy. Lancet. 1998:351;867-870.
9. Wurtz R. Buffalo hump in HIV. Lancet. 1998;351:1735-1736.
10. Schindler JT, Sponer KM, Decker CF. Buffalo humps associated with protease inhibitors. Ann Intern Med. 1998;129:164.
11. th Conference on Retroviruses and Opportunistic Infections, 1998. Abstract # 414.
12. Sullivan AK, Feher MD, Nelson MR, Gazzard BG. Marked hypertriglyceridemia on Ritonavir. AIDS. 1998;12:1393-1394.
13. Walli RK, Hefort O, Michl GM, Demant T, Jager H, Dieterle C, Bogner JR, Landgraf R, Geobel FD. Peripheral insulin resistance leading to impaired glucose tolerance in HIV infected patients treated with protease inhibitors. AIDS. 1998;12:F167-173.
14. Carr A, Samaras K, Chisolm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor associated peripheral lipodystrophy, hyperlipidemia, and insulin resistance. Lancet. 1998:352;1881-1883.
15. Miller K, Jones E, Yanovski J, Shankar R, Feuerstein I, Falloon J. Visceral abdominal fat accumulation associated with use of indinavir. Lancet. 1998:351:871-875.
16. th World AIDS Conference, 1998. Abstract #32181.
17. th World AIDS Conference, 1998. Abstract #32173.
18. Wanke CA. Epidemiological and clinical aspects of the metabolic complications of HIV infection: the fat redistribution syndrome. AIDS. 1999;13:1287-1294.
19. Durnin JVGA, Wormersley J. Body fat assessed from total body density and its estimation from skinfold thickness measurement of 481 men and women aged 16 to 72 years. Br J Nutr. 1974;32:77-96.
20. Callaway CW, Chumlea WC, Bouchard C, Himes JH, Lohman GT, Martin AD, Mitchell CD, Mueller WH, Roche AF, Seefeldt VD. Anthropometric Standardization Reference Manual. Champaign, III: Human Kinetics Books, 1988.
21. Frisancho AR. New norms of upper limb fat and muscle areas for assessment for nutritional status. Am J Clin Nutr. 34:2540-2545, 1981.
22. Lukaski HC. Use of BIA to assess human body composition: a review. In Livingston GE, ed. Nutritional Assessment of the Individual. Trumball Conn: Food and Nutrition Press. Inc. 189-204, 1989.
23. th Conference on antiretroviral therapy, Chicago, 1999. Abstract # 651.
24. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection . AIDS. 1999;13(18):2493-2505.
25. Schwenk, A, Beisenherz A, KremerG, Diehl V, Salzberger B, Fäkenheuer. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr. 1999;70:867-873.
26. Spiegelman D, Israel RG, Bouchard C, Willett WC. Abdominal fat mass, percent body fat, and body fat distribution: which is the real determinant of blood pressure and glucose. Am J Clin Nutr. 1992;55:1033-1044.